Interventions to Reduce Alcohol Use among HIV/TB Individuals in Uganda
Funded by National Institute on Alcohol Abuse and Alcoholism
Globally, approximately 25% of persons with HIV are heavy drinkers, and heavy alcohol use is associated with a 3-fold higher risk of Tuberculosis (TB) disease compared to no alcohol use, thus HIV-infected persons who drink alcohol are at high risk for TB. As a Co-Investigator, Dr. McDonell provides his expertise as the investigative team and research staff in Uganda use an incentive- based intervention to reduce alcohol use and increase medication safety in Uganda using ethyl glucuronide (EtG) dipsticks to test for alcohol use. This study seeks to provide new information on low-cost strategies to reduce alcohol use and increase isoniazid preventative therapy adherence in low-income countries.
University of California, San Francisco
Judith Hahn, Ph.D.
Collaborative International Partnership with Brazil
For several years, our BHI lab as well as other faculty members in the Elson S Floyd College of Medicine (Drs. Roll and McPherson) have served as a leading academic partner, working in São Paulo, Brazil to promote effective substance use treatment and public health practices.
Washington State University Team
Michael McDonell, Ph.D.
Sterling McPherson, Ph.D.
John Roll, Ph.D.
Oladunni Oluwoye, Ph.D.
Federal University of São Paulo
Clarice Madruga, Ph.D., Public Health Official and Assistant Professor
Andre Miguel, Ph.D., Postdoctoral Fellow Yale School of Medicine